Generic Oncology Drugs Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast Period
In 2022, the generic oncology drugs market was estimated to be worth USD 28.9 billion, with a compound annual growth rate (CAGR) of 5.3% anticipated for the projected period. The global cancer patient population is growing, which is propelling market expansion. The market is growing rapidly as a result of generic medications' declining costs. Generic oncology medications are in high demand as the cost of cancer therapy continues to soar. Increased investment in this area by pharmaceutical companies is fueling the market's need for generic cancer medications. The market is expanding significantly due to rising population levels, altered dietary habits, and increased UV radiation exposure. Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/generic-oncology-drugs-market Growth Drivers The branded pharma industry's patent expiration, rising cancer rates, and major companies' investments in immunotherapy, targeted therapy, and...